Neogenomics (NEO) Share-based Compensation Growth (1y) (2011 - 2026)
Neogenomics (NEO) Share-based Compensation Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | 1.23% |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | 2.20% |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | 8.31% |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | 0.00% |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | 58.33% |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | - |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | 5.80% |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | -0.20% |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | 500.00% |
| 10 | Neogenomics | 2.05 Bn | 1.90 Bn | 91.88 Mn | -32.73% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -32.73% |
| Mar 31, 2026 | -10.40% |
| Dec 31, 2025 | -3.43% |
| Jun 30, 2025 | 6,007.00% |
| Mar 31, 2025 | 38.33% |
| Dec 31, 2024 | 19.14% |
| Mar 31, 2024 | 63.39% |
| Dec 31, 2023 | 49.90% |
| Mar 31, 2023 | -60.69% |
| Dec 31, 2022 | -53.66% |
| Sep 30, 2022 | -18.27% |
| Jun 30, 2022 | -19.53% |
| Mar 31, 2022 | 356.20% |
| Dec 31, 2021 | 276.01% |
| Sep 30, 2021 | 92.89% |
| Jun 30, 2021 | 71.01% |
| Mar 31, 2021 | 21.36% |
| Dec 31, 2020 | 17.73% |
| Sep 30, 2020 | -17.10% |
| Jun 30, 2020 | 13.92% |